The global bioanalytical testing services industry was valued at US$ 2.11 Bn in 2021
The global market is projected to advance at a CAGR of 15.7% from 2022 to 2031
The global market is anticipated to reach more than US$ 8.95 Bn by 2031
Analysts’ Viewpoint on Bioanalytical Testing Services Market Scenario
Bioanalytical testing is used for quantitative determination of properties of drugs and metabolites in biological fluids, primarily blood, plasma, serum, urine, or tissue extracts. Rise in demand for biopharma products and growth in usage of biosimilars for different indications, especially diabetes and cancer, are key factors projected to drive the global market. Most of the pharmaceutical companies, bioanalytical laboratories, and CROs are scaling up their bioanalytical services and investing in bioanalytical testing laboratories.
Rise in demand for biopharma products and increase in need to develop novel bioanalytical assay platforms are the key factors driving investments in bioanalytical R&D and laboratories. Increase in trend of outsourcing laboratory testing services for quality check has encouraged companies to offer various types of services and solutions in the market. This is anticipated to propel the market. Growth in merger and acquisition activities across the globe is also augmenting the demand for bioanalytical assay services. For instance, in October 2021, BioAgilytix signed an agreement to acquire Australia-based 360biolabs.
Bioanalytical diagnostic technologies play a crucial role in containing the COVID-19 pandemic. They are likely to help contain the future waves of the pandemic and infectious disease outbreaks. In the event of a major pandemic such as COVID-19, a combination of different diagnostic technologies (centralized and point-of-care, and reliance on multiple biomarkers) is required for effective diagnosis, treatment selection, prognosis, patient monitoring, and epidemiological surveillance.
Several biotech and pharmaceutical companies have been focusing on developing effective technologies for rapid diagnosis of COVID-19. They have been concentrating on developing vaccines/therapeutics that can help mitigate the spread of the disease by ensuring appropriateness of care across all healthcare settings and achieving high-quality outcomes. This is driving the demand for bioanalytical assay services across the globe. For instance, CIRION BioPharma Research, Inc., a GLP-certified contract research laboratory based in the U.S., announced in July 2020 that it was expanding its bioanalytical testing services to support COVID-19 drug and vaccine development.
Immunogenicity testing is required throughout the development process to assess the immune response in preclinical models using clinical samples. Immunogenicity testing examines antibodies created against a treatment. It helps establish efficacy and safety with assurance in vaccine and biologics production or gene therapy. Hence, immunology bioanalytical tests are crucial in the clinical phase for practically all modern medicines, from monoclonal antibodies (mAbs) for oncology to vaccine programs and gene & cell therapies. Any therapy that provokes an immune response requires clinical immunological testing to ensure that the response does not jeopardize patient safety. In terms of application, immunology is likely to be the fastest growing segment of the global market during the forecast period. Therefore, increase in usage of immunogenicity and immune-based therapy is projected to boost the immunology segment during the forecast period.
The mass spectrometry segment is projected to account for major share of the global bioanalytical testing services market by 2031. R&D spending by pharmaceutical companies has increased significantly in the last two decades. Biopharmaceutical research is supported by investments in specialties such as biopharma and precision medicine. The study of large molecules is currently a hot topic of discussion in the bioanalytical community. Growing importance of peptides and proteins as therapeutic agents, combined with the significant opportunities provided by new MS-based technology, has opened up a whole new world for bioanalytical scientists. Rise in usage of mass spectrometers in pharmaceutical and biopharmaceutical industries and adoption of new applications in the bioanalytical testing services industry are the key factors driving the mass spectroscopy segment.
Based on end-user, the biotech & pharmaceutical companies segment is projected to advance at a CAGR of 15.1% during the forecast period. Biotech and pharmaceutical companies are focusing on specialized testing services including gene expression analysis, liquid chromatography-mass spectrometry (LC/MS), raw material wet chemistry analysis, and metal analysis with inductive mass spectrometry (ICP-MS). Furthermore, pharmaceutical companies are increasing outsourcing of early-phase development, clinical, and laboratory testing services to boost revenue, avoid high capital spending, and decrease the time taken to validate processes and products.
North America is projected to be a highly attractive region of the global market during the forecast period. The region accounted for more than 45% share of the global market in 2021 due to the presence of large number of patients with various chronic diseases and rise in adoption of peptides and other large molecule therapeutics. According to the Centers for Disease Control and Prevention, more than 877,500 people in the U.S. succumb to heart disease or stroke every year (i.e., one-third of all deaths). These diseases take an economic toll, costing the health care system US$ 216 Bn per year.
Europe was the second largest bioanalytical testing services market in terms of revenue in 2021. High share of the region can be ascribed to the increase in investment in biotechnology and pharmaceutical R&D activities. Furthermore, rise in in cases of chronic diseases is driving the market in Europe. For instance, cardiovascular disease (CVD) accounted for 3.9 million deaths in Europe in 2017. Around 15% of CVD deaths in the region are due to high blood sugar. Prevalence of diabetes in the region is high. It has increased rapidly in the past 10 years, rising by more than 50% in several countries in the region. Hence, increase in incidence of diseases is propelling the market in Europe.
The market in Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. Increase in clinical trial activities in emerging markets is primarily ascribed to factors such as cost savings, large treatment-naive population, retention of clinical trial participants, and constantly improving regulatory procedures. Furthermore, China's bioanalytical testing services have increased due to the growth in drug innovation and development activities in the last decade. This is expected to drive the market in the country during the forecast period.
This report includes vital information about the key players operating in the global bioanalytical testing services market. Companies are focusing on strategies such as new product launches, divestiture, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market. Charles River Laboratories International, Inc., Bioreliance Corporation, Intertek Group plc, Eurofins Scientific SE, BioclinResearch Laboratories, Labcorp, Wuxi AppTec, Envigo, BioAgilytix Labs, Syneos Health, and Frontage Labs are the prominent players operating in the global market.
Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 2.11 Bn |
|
Market Forecast Value in 2031 |
More than US$ 8.95 Bn |
|
Compound Annual Growth Rate (CAGR) |
15.7% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market was valued at US$ 2.11 Bn in 2021.
The global market is projected to reach more than US$ 8.95 Bn by 2031.
The global market grew at a CAGR of 6% from 2017 to 2021.
The global market is anticipated to grow at a CAGR of 15.7% from 2022 to 2031.
Rise in investment in R&D facilities, surge in demand for biopharma products, and increase in need to develop novel bioanalytical testing platforms are the key factors driving the global market.
The cell-based bioassay segment accounted for more than 30% share of the global market in 2021.
North America is expected to account for major share of the global market during the forecast period.
Charles River Laboratories International Inc., Bioreliance Corporation, Intertek Group plc, Eurofins Scientific SE, BioclinResearch Laboratories, Labcorp, Wuxi AppTec, Envigo, BioAgilytix Labs, SyneosHealth, and Frontage Labs are the prominent players operating in the global market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioanalytical Testing Services Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioanalytical Testing Services Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Pipeline Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Bioanalytical Testing Services Market Analysis and Forecast, by Testing Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Testing Type, 2017–2031
6.3.1. Cell-based Assays
6.3.2. Virology Testing
6.3.3. Serology, Immunogenicity, and Neutralizing Antibodies
6.3.4. Toxicology Services
6.3.5. Biomarker Testing
6.3.6. Pharmacokinetic Testing
6.3.7. Other services
6.4. Market Attractiveness Analysis, by Testing Type
7. Global Bioanalytical Testing Services Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Oncology
7.3.2. Metabolic Disorders
7.3.3. Neurology
7.3.4. Hematology
7.3.5. Orthopedics
7.3.6. Immunology
7.3.7. Other
7.4. Market Attractiveness Analysis, by Application
8. Global Bioanalytical Testing Services Market Analysis and Forecast, by Technology
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Technology, 2017–2031
8.3.1. Mass Spectrometry
8.3.2. Chromatography
8.3.3. Others
8.4. Market Attractiveness Analysis, by Technology
9. Global Bioanalytical Testing Services Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Healthcare Institutes
9.3.2. Biotech & Pharmaceuticals Company
9.3.3. CDMO & CMO
9.3.4. Clinical Research Organizations
9.4. Market Attractiveness Analysis, by End-user
10. Global Bioanalytical Testing Services Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Bioanalytical Testing Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Testing Type, 2017–2031
11.2.1. Cell-based Assays
11.2.2. Virology Testing
11.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
11.2.4. Toxicology Services
11.2.5. Biomarker Testing
11.2.6. Pharmacokinetic Testing
11.2.7. Other services
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Oncology
11.3.2. Metabolic Disorders
11.3.3. Neurology
11.3.4. Hematology
11.3.5. Orthopedics
11.3.6. Immunology
11.3.7. Other
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. Mass Spectrometry
11.4.2. Chromatography
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Healthcare Institutes
11.5.2. Biotech & Pharmaceuticals Company
11.5.3. CDMO & CMO
11.5.4. Clinical Research Organizations
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Testing Type
11.7.2. By Application
11.7.3. By Technology
11.7.4. By End-user
11.7.5. By Country
12. Europe Bioanalytical Testing Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Testing Type, 2017–2031
12.2.1. Cell-based Assays
12.2.2. Virology Testing
12.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
12.2.4. Toxicology Services
12.2.5. Biomarker Testing
12.2.6. Pharmacokinetic Testing
12.2.7. Other Services
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Oncology
12.3.2. Metabolic Disorders
12.3.3. Neurology
12.3.4. Hematology
12.3.5. Orthopedics
12.3.6. Immunology
12.3.7. Other
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. Mass Spectrometry
12.4.2. Chromatography
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Healthcare Institutes
12.5.2. Biotech & Pharmaceuticals Company
12.5.3. CDMO & CMO
12.5.4. Clinical Research Organizations
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Testing Type
12.7.2. By Application
12.7.3. By Technology
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Bioanalytical Testing Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Testing Type, 2017–2031
13.2.1. Cell-based Assays
13.2.2. Virology Testing
13.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
13.2.4. Toxicology Services
13.2.5. Biomarker Testing
13.2.6. Pharmacokinetic Testing
13.2.7. Other Services
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Oncology
13.3.2. Metabolic Disorders
13.3.3. Neurology
13.3.4. Hematology
13.3.5. Orthopedics
13.3.6. Immunology
13.3.7. Other
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. Mass Spectrometry
13.4.2. Chromatography
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Healthcare Institutes
13.5.2. Biotech & Pharmaceuticals Company
13.5.3. CDMO & CMO
13.5.4. Clinical Research Organizations
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Testing Type
13.7.2. By Application
13.7.3. By Technology
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Bioanalytical Testing Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Testing Type, 2017–2031
14.2.1. Cell-based Assays
14.2.2. Virology Testing
14.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
14.2.4. Toxicology Services
14.2.5. Biomarker Testing
14.2.6. Pharmacokinetic Testing
14.2.7. Other Services
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Oncology
14.3.2. Metabolic Disorders
14.3.3. Neurology
14.3.4. Hematology
14.3.5. Orthopedics
14.3.6. Immunology
14.3.7. Other
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. Mass Spectrometry
14.4.2. Chromatography
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Healthcare Institutes
14.5.2. Biotech & Pharmaceuticals Company
14.5.3. CDMO & CMO
14.5.4. Clinical Research Organizations
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Testing Type
14.7.2. By Application
14.7.3. By Technology
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Bioanalytical Testing Services Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Testing Type, 2017–2031
15.2.1. Cell-based Assays
15.2.2. Virology Testing
15.2.3. Serology, Immunogenicity, and Neutralizing Antibodies
15.2.4. Toxicology Services
15.2.5. Biomarker Testing
15.2.6. Pharmacokinetic Testing
15.2.7. Other Services
15.3. Market Value Forecast, by Application, 2017–2031
15.3.1. Oncology
15.3.2. Metabolic Disorders
15.3.3. Neurology
15.3.4. Hematology
15.3.5. Orthopedics
15.3.6. Immunology
15.3.7. Other
15.4. Market Value Forecast, by Technology, 2017–2031
15.4.1. Mass Spectrometry
15.4.2. Chromatography
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Healthcare Institutes
15.5.2. Biotech & Pharmaceuticals Company
15.5.3. CDMO & CMO
15.5.4. Clinical Research Organizations
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Testing Type
15.7.2. By Application
15.7.3. By Technology
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.3. Company Profiles
16.3.1. Charles River Laboratories International, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. Bioreliance Corporation
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Intertek Group plc
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. Eurofins Scientific SE
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. BioclinResearch Laboratories
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Labcorp
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Wuxi AppTec
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Envigo
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. BioAgilytix Labs
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. SyneosHealth
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview
16.3.11. Frontage Labs
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Strategic Overview
List of Tables
Table 01: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031
Table 02: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031
Table 03: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 04: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 05: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by technology, 2017‒2031
Table 06: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by technology, 2017‒2031
Table 07: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 08: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 09: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031
Table 10: North America Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031
Table 11: North America Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031
Table 12: North America Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031
Table 15: Europe Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031
Table 16: Europe Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031
Table 17: Europe Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 18: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 19: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031
Table 20: Asia Pacific Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031
Table 21: Asia Pacific Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031
Table 22: Asia Pacific Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 23: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 24: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031
Table 25: Latin America Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031
Table 26: Latin America Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031
Table 27: Latin America Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 28: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 29: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031
Table 30: Middle-East & Africa Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031
Table 31: Middle-East & Africa Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031
Table 32: Middle-East & Africa Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Bioanalytical Testing Services Market Value Share, by Testing Type, 2021
Figure 03: Global Bioanalytical Testing Services Market Value Share, by Technology, 2021
Figure 04: Global Bioanalytical Testing Services Market Value Share, by Application, 2021
Figure 05: Global Bioanalytical Testing Services Market Value Share, by End-user, 2021
Figure 06: Global Bioanalytical Testing Services Market Value Share, by Region, 2021
Figure 07: Global Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031
Figure 08: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031
Figure 09: Global Bioanalytical Testing Services Market (US$ Mn), by Cell-based Assays, 2017–2031
Figure 10: Global Bioanalytical Testing Services Market (US$ Mn), by Virology Testing, 2017–2031
Figure 11: Global Bioanalytical Testing Services Market (US$ Mn), by Serology, Immunogenicity, and Neutralizing Antibodies, 2017–2031
Figure 12: Global Bioanalytical Testing Services Market (US$ Mn), by Toxicology Services, 2017–2031
Figure 13: Bioanalytical Testing Services Market (US$ Mn), by Biomarker Testing, 2017–2031
Figure 14: Global Bioanalytical Testing Services Market (US$ Mn), by Pharmacokinetic Testing, 2017–2031
Figure 15: Global Bioanalytical Testing Services Market (US$ Mn), by Other services, 2017–2031
Figure 16: Global Bioanalytical Testing Services Market, by Application, 2021 and 2031
Figure 17: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2022–2031
Figure 18: Global Bioanalytical Testing Services Market (US$ Mn), by Oncology, 2017–2031
Figure 19: Global Bioanalytical Testing Services Market (US$ Mn), by Metabolic Disorders, 2017–2031
Figure 20: Global Bioanalytical Testing Services Market (US$ Mn), by Neurology, 2017–2031
Figure 21: Global Bioanalytical Testing Services Market (US$ Mn), by Hematology, 2017–2031
Figure 22: Global Bioanalytical Testing Services Market (US$ Mn), by Orthopedics, 2017–2031
Figure 23: Global Bioanalytical Testing Services Market (US$ Mn), by Immunology, 2017–2031
Figure 24: Global Bioanalytical Testing Services Market (US$ Mn), by Other, 2017–2031
Figure 25: Global Bioanalytical Testing Services Market, by Technology 2021 and 2031
Figure 26: Global Bioanalytical Testing Services Market Attractiveness Analysis, Technology, 2022–2031
Figure 27: Global Bioanalytical Testing Services Market (US$ Mn), by Mass Spectrometry, 2017–2031
Figure 28: Global Bioanalytical Testing Services Market (US$ Mn), by Chromatography, 2017–2031
Figure 29: Global Bioanalytical Testing Services Market (US$ Mn), by Others, 2017–2031
Figure 30: Global Bioanalytical Testing Services Market, by End-user 2021 and 2031
Figure 31: Global Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031
Figure 32: Global Bioanalytical Testing Services Market (US$ Mn), by Healthcare Institutes, 2017–2031
Figure 33: Global Bioanalytical Testing Services Market (US$ Mn), by Biotech & Pharmaceuticals Company, 2017–2031
Figure 34: Global Bioanalytical Testing Services Market (US$ Mn), by CDMO & CMO, 2017–2031
Figure 35: Global Bioanalytical Testing Services Market (US$ Mn), by Clinical Research Organizations, 2017–2031
Figure 36: Global Bioanalytical Testing Services Market Value Share Analysis, by Region, 2021 and 2031
Figure 37: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Region, 2022–2031
Figure 38: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 39: North America Bioanalytical Testing Services Market Value Share Analysis, by Country, 2021 and 2031
Figure 40: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Country, 2022–2031
Figure 41: North America Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031
Figure 42: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031
Figure 43: North America Bioanalytical Testing Services Market, Technology, 2021 and 2031
Figure 44: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031
Figure 45: North America Bioanalytical Testing Services Market, by Application, 2021 and 2031
Figure 46: North America Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031
Figure 47: North America Bioanalytical Testing Services Market, by End-user, 2021 and 2031
Figure 48: North America Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031
Figure 49: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Europe Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 51: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 52: Europe Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031
Figure 53: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031
Figure 54: Europe Bioanalytical Testing Services Market, Technology, 2021 and 2031
Figure 55: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031
Figure 56: Europe Bioanalytical Testing Services Market, by Application, 2021 and 2031
Figure 57: Europe Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031
Figure 58: Europe Bioanalytical Testing Services Market, by End-user, 2021 and 2031
Figure 59: Europe Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031
Figure 60: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 61: Asia Pacific Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 62: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 63: Asia Pacific Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031
Figure 64: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031
Figure 65: Asia Pacific Bioanalytical Testing Services Market, Technology, 2021 and 2031
Figure 66: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031
Figure 67: Asia Pacific Bioanalytical Testing Services Market, by Application, 2021 and 2031
Figure 68: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031
Figure 69: Asia Pacific Bioanalytical Testing Services Market, by End-user, 2021 and 2031
Figure 70: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031
Figure 71: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 72: Latin America Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 73: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 74: Latin America Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031
Figure 75: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031
Figure 76: Latin America Bioanalytical Testing Services Market, Technology, 2021 and 2031
Figure 77: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031
Figure 78: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2021 and 2031
Figure 79: Latin America Bioanalytical Testing Services Market, Application, 2022–2031
Figure 80: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by End-user, 2021 and 2031
Figure 81: Latin America Bioanalytical Testing Services Market, End-user, 2022–2031
Figure 82: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 83: Middle-East & Africa Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 84: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 85: Middle-East & Africa Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031
Figure 86: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031
Figure 87: Middle-East & Africa Bioanalytical Testing Services Market, Technology, 2021 and 2031
Figure 88: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031
Figure 89: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2021 and 2031
Figure 90: Middle-East & Africa Bioanalytical Testing Services Market, Application, 2022–2031
Figure 91: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by End-user, 2021 and 2031
Figure 92: Middle-East & Africa Bioanalytical Testing Services Market, End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bioanalytical Testing Services Market
